| Entorhinal Cortex Stellate Cells (Layer II) | |
|---|---|
| Lineage | Neuron > Glutamatergic > Cortical > Entorhinal Layer II |
| Markers | RELN (Reelin), CXCL14, SLC17A7, CALB2, ER81 |
| Brain Regions | [Medial Entorhinal Cortex](/brain-regions/entorhinal-cortex) (Layer II), [Lateral Entorhinal Cortex](/brain-regions/entorhinal-cortex) (Layer II) |
| Disease Vulnerability | [Alzheimer's Disease](/diseases/alzheimers-disease), [Frontotemporal Dementia](/diseases/ftd) |
Entorhinal cortex stellate cells are excitatory glutamatergic neurons located in layer II of the entorhinal cortex that serve as the principal gateway for cortical information entering the hippocampal memory system. These reelin-expressing neurons project to the dentate granule cells and CA3 via the perforant pathway, forming one of the most critical circuits for episodic memory formation [1][2]. In the medial entorhinal cortex, stellate cells include grid cells — neurons that fire in hexagonal spatial patterns to create an internal map of space — making them essential for spatial navigation and path integration [3].
Layer II stellate cells are among the earliest and most severely affected neurons in Alzheimer's disease [1][4]. Abnormally phosphorylated tau protein first appears in the entorhinal cortex during Braak stages I–II, decades before clinical symptoms emerge, and the selective loss of these neurons disrupts hippocampal input, contributing to the characteristic memory impairment of early AD [4]. Understanding why these specific cells are so vulnerable is one of the central questions in Alzheimer's research.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000122 | stellate neuron |
Stellate cells are defined by their distinctive star-shaped dendritic morphology in layer II of the entorhinal cortex [3]:
The defining molecular marker of layer II stellate cells is reelin (RELN), a large extracellular matrix glycoprotein that distinguishes them from calbindin-positive pyramidal neurons in the same layer [1][5]:
In the medial entorhinal cortex (MEC), stellate cells include multiple functional types [3]:
In the lateral entorhinal cortex (LEC), stellate-like "fan cells" process object and context information rather than spatial signals, projecting to the dentate gyrus to encode "what" alongside the MEC's "where" information.
Stellate cells are the origin of the perforant pathway, the major excitatory input to the hippocampus [2]. This trisynaptic circuit is essential for memory:
Layer II stellate cells also project directly to CA3, providing an additional route for cortical information to reach the hippocampus. The fidelity and integrity of these projections are critical for pattern separation, spatial memory, and episodic memory encoding.
The discovery of grid cells in medial entorhinal stellate cells by Moser and Moser (2005 Nobel Prize in Physiology or Medicine, 2014) revealed that these neurons create an internal metric coordinate system for space [3]. Grid cell firing patterns are thought to arise from the unique electrophysiological properties of stellate cells, particularly their subthreshold membrane potential oscillations at theta frequency (4–12 Hz), which support path integration computations.
Stellate cells display distinctive electrophysiological properties that set them apart from pyramidal neurons:
Layer II entorhinal stellate cells are the first neurons in the brain to develop tau pathology. This extraordinary selective vulnerability unfolds according to the Braak staging system:
Multiple converging factors render stellate cells uniquely susceptible to neurodegeneration [1][5]:
Reelin depletion: Reelin expression in layer II neurons is reduced in AD patient tissue and in animal models. Critically, naturally occurring variation in age-related cognitive decline correlates with loss of reelin expression, even independently of AD pathology [5]. Reelin normally promotes synaptic plasticity, enhances long-term potentiation, and reduces tau phosphorylation — its loss removes a key neuroprotective mechanism.
BDNF signaling deficit: Reduced BDNF (brain-derived neurotrophic factor) and acidic fibroblast growth factor (aFGF) create a hostile microenvironment for layer II neurons [5]. Factors that increase AD risk — sedentary behavior, excessive caloric intake, diabetes — simultaneously reduce BDNF levels, providing a mechanistic link between lifestyle risk factors and selective neuronal vulnerability.
Neuroinflammatory exposure: The entorhinal cortex receives dense vascular input from multiple cerebral arteries, potentially exposing layer II neurons to elevated proinflammatory cytokines including TNF-α and MCP-1 [5]. Activated microglia in the entorhinal cortex release inflammatory mediators that can directly damage vulnerable stellate cells.
High metabolic demand: Stellate cells have high basal metabolic activity due to their role in continuous spatial computation and their extensive dendritic arbors. This makes them particularly susceptible to mitochondrial dysfunction and oxidative stress, both implicated in AD pathogenesis.
Unique tau phosphorylation patterns: Layer II neurons express specific tau kinase and phosphatase combinations (including elevated GSK3β and reduced PP2A activity) that may promote pathological tau aggregation more readily than in other neuronal populations.
The loss of entorhinal stellate cells has profound consequences for hippocampal function:
The early involvement of stellate cells in AD makes them attractive therapeutic targets:
Given the role of neuroinflammation in selective vulnerability:
Emerging approaches aim to replace lost stellate cells:
| Mechanism | Role in Vulnerability | Therapeutic Target |
|---|---|---|
| Reelin depletion | Loss of neuroprotection | Reelin agonists |
| BDNF deficit | Reduced trophic support | BDNF/TrkB agonists |
| Neuroinflammation | Direct neuronal damage | Anti-inflammatory drugs |
| Oxidative stress | Mitochondrial dysfunction | Antioxidants |
| Tau hyperphosphorylation | Pathological aggregation | Kinase inhibitors |
| Gene | Function | AD Relevance |
|---|---|---|
| RELN | Extracellular matrix protein; promotes LTP | Protective; downregulated in AD |
| BDNF | Neurotrophic factor | Protective; reduced in AD |
| GSK3β | Tau kinase | Promotes tau pathology |
| CDK5 | Tau kinase | Activated in AD |
| PP2A | Tau phosphatase | Reduced activity in AD |
| SLC17A7 | Vesicular glutamate transporter | Marker of excitatory identity |
| CXCL14 | Chemokine | Enriched in stellate cells |